A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship

ConditionLymphoma

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorMassachusetts General Hospital

About this trial

The goal of this trial is to learn if a resilience intervention can lead to improvements in lymphoma survivors' quality of life.

English or Spanish speaking adults (18+ at time of enrollment)

Within 2 years of completing active, curative treatment for lymphoma (includes surgery, chemotherapy, immunotherapy, radiation therapy, or other)

Active psychiatric or cognitive comorbidity as determined by the site PI or treating clinician

254 Participants

are divided into 2 treatment groups

Massachusetts General Hospital

Lead sponsor